gamma-synuclein (114-127) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-gamma-synuclein (114-127) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | gamma-synuclein (114-127) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, rat |
| Isotype | n/a |
| Format | unconjugated |
| Size | 0.1 mL |
| Concentration | 1ug/ul |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Immunohistochemical/western blot anlysis indicate a high level of specificity for this antiserum for gamma synuclein. FUNCTION: Plays a role in neurofilament network integrity. May be involved in modulating axonal architecture during development and in the adult. In vitro, increases the susceptibility of neurofilament-H to calcium-dependent proteases. May also function in modulating the keratin network in skin. Activates the MAPK and Elk-1 signal transduction pathway. SUBUNIT: May be a centrosome-associated protein. SUBCELLULAR LOCATION: Cytoplasm; perinuclear region. Centrosome. Spindle. Associated with centrosomes in several interphase cells. In mitotic cells, localized to the poles of the spindle. TISSUE SPECIFICITY: Highly |
| Immunogen | Immunogen: A synthetic peptide (EKEEVAEEAQSGGD) as part of human gamma synuclein protein (aa: 114-127) conjugated to diphteria toxid has been used as the immunogen. Storage Buffer: PBS, pH 7.4 with 0.02% sodium azide. |
| Other Names | n/a |
| Gene, Accession # | n/a |
| Catalog # | MBS4152682 |
| Price | $515 |
| Order / More Info | gamma-synuclein (114-127) Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies